Literature DB >> 4965698

The provocation of latent lymphocytic choriomeningitis virus infections in mice by treatment with antilymphocytic serum.

M Volkert, C Lundstedt.   

Abstract

The hypothesis that treatment with antilymphocytic serum (ALS) can provoke latent virus infections has been investigated. In adult mice infections with sublethal doses of LCM virus usually result in the development of immunity to the virus and at the same time to a prolonged latent infection. In the experiments described an intensive treatment with large doses of ALS was given to mice which had recovered from LCM virus infection. At the beginning of the treatment the mice had high titers of complement-fixing antibodies in their blood and no detectable virus. The data presented show that in spite of the immunity the ALS treatment provoked the occult virus and led to the development of viremia in all the treated mice. In some, very high virus titers were demonstrable. When the ALS treatment was discontinued the viremia disappeard again. In most of the mice the ALS did not suppress the complement-fixing antibody titers and in some there was even a considerable increase in titer. In such cases the increases in virus titers and in antibody titers were closely related to one another. These results demonstrate once again that the complement-fixing antibodies to the LCM virus in mice probably do not influence the virus.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4965698      PMCID: PMC2138450          DOI: 10.1084/jem.127.2.327

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS.

Authors:  M VOLKERT; J H LARSEN; C PFAU
Journal:  Acta Pathol Microbiol Scand       Date:  1964

2.  Studies of lymphocytic choriomeningitis in mice. II. A comparison of the immune status of newborn and adult mice surviving inoculation.

Authors:  H WEIGAND; J HOTCHIN
Journal:  J Immunol       Date:  1961-04       Impact factor: 5.422

3.  Virus Neutralisation experiments with lymphoid cell- and lymph node-extracts.

Authors:  J SINKOVICS
Journal:  Acta Microbiol Acad Sci Hung       Date:  1955

4.  Some relationships between lymphocytic choriomeningitis (LCM) virus and mice.

Authors:  V H HAAS
Journal:  J Infect Dis       Date:  1954 Mar-Apr       Impact factor: 5.226

5.  Effect of donor antigen on dogs with renal homotransplants.

Authors:  R Y Calne; D R Davis; P Medawar; J R Wheeler
Journal:  Transplantation       Date:  1966-11       Impact factor: 4.939

6.  Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties.

Authors:  J G Gray; A P Monaco; M L Wood; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

Review 7.  Immunological tolerance to viruses.

Authors:  M Volkert; J H Larsen
Journal:  Prog Med Virol       Date:  1965

Review 8.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

9.  CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS.

Authors:  E MOELLER
Journal:  Science       Date:  1965-02-19       Impact factor: 47.728

10.  A SOLUBLE ANTIGEN OF LYMPHOCYTIC CHORIOMENINGITIS : II. INDEPENDENCE OF ANTI-SOLUBLE SUBSTANCE ANTIBODIES AND NEUTRALIZING ANTIBODIES, AND THE ROLE OF SOLUBLE ANTIGEN AND INACTIVE VIRUS IN IMMUNITY TO INFECTION.

Authors:  J E Smadel; M J Wall
Journal:  J Exp Med       Date:  1940-09-30       Impact factor: 14.307

View more
  23 in total

Review 1.  A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.

Authors:  D Wodarz; K M Page; R A Arnaout; A R Thomsen; J D Lifson; M A Nowak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

2.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Immunosuppressive agents in intracellular infection: besnoitiosis in hamsters.

Authors:  H R Wilson; J K Frenkel
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

4.  Defects in the immune system of mice infected with lymphocytic choriomeningitis virus.

Authors:  K Bro-Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

Review 5.  Persistent infection of the mouse with the virus of lymphocytic choriomeningitis.

Authors:  F Lehmann-Grube
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

6.  Interferon response of lymphocytes in disorders with decreased resistance to infections.

Authors:  H Strander; K Cantell; J Leisti; E Nikkila
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

7.  A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.

Authors:  Devon J Shedlock; Kendra T Talbott; Christina Cress; Bernadette Ferraro; Steven Tuyishme; Karthik Mallilankaraman; Neil J Cisper; Matthew P Morrow; Stephan J Wu; Omkar U Kawalekar; Amir S Khan; Niranjan Y Sardesai; Karuppiah Muthumani; Hao Shen; David B Weiner
Journal:  Vaccine       Date:  2011-01-14       Impact factor: 3.641

8.  DNA vaccination against persistent viral infection.

Authors:  L P Martins; L L Lau; M S Asano; R Ahmed
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

Review 9.  Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.

Authors:  E Gleichmann; H Gleichmann
Journal:  Klin Wochenschr       Date:  1973-03-15

10.  Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans.

Authors:  D M Adamson; G C Cozad
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.